Addressing Transient Elastography (FibroScan): Integrating ... · World Health Organization ......

Post on 12-Jul-2020

1 views 0 download

Transcript of Addressing Transient Elastography (FibroScan): Integrating ... · World Health Organization ......

Addressing Transient Elastography (FibroScan): Integrating with HCV Care

Justin Iwasaki MD MPH

Executive Medical Director

Lummi Tribal Health Center

HCV ELIMINATION

Describe Hepatitis C Elimination Program

Introduce Fibroscan Technology

HCV ELIMINATION

Elimination

Reduction to zero of the incidence of disease or

infection in a defined geographical area.

World Health Organization

http://www.who.int/bulletin/volumes/84/2/editorial10206html/en/

Source: National Notifiable Diseases Surveillance

System (NNDSS)

80% of New HCV Infections Occur in People Who

Inject Drugs (PWID)

HCV ELIMINATION

HCV Program Design Considerations

PWID May Not Fit the Usual Healthcare Delivery Model We Created

Scheduled Office Visits

Follow Up with Testing and Imaging and Future Appointments

Convenient Contact with Telephone or Mail

Reliable Transportation

Ability to Safely Store Medication

Predictable Changes to Home Life: Hospitalization, Incarceration,

Drug/Alcohol Rehab

Family and Friend Support

HCV ELIMINATION

We Had to Create A New Model of Healthcare Delivery

HCV ELIMINATION

Initially, required multiple visits, could not get

outside imaging, significant amount of

human resources.

Single Visit Ready to Treat Program

Rapid HCV Ab Test

HCV RNA with Reflex to

Genotype (standing orders)

BMP

LFT

INR

CBC

*Fibroscan*

Re-Screen Based on

Exposure History

Positive Negative

Chronic HCV OR No Chronic HCV

Retest HCV

RNA q6month

Present to Project ECHO

Start Treatment

Submit Prior Authorization

Day 0

4-6 Weeks

Day 1

> F1 and HCV RNA Positive

*Data Mining* Previous HCV Ab/RNA

Fibroscan: calculates liver stiffness based

on sound wave.

Non-invasive. 10-15 Minutes.

RN, Rad Tech, MD

HCV ELIMINATION

HCV ELIMINATION

Fibroscan Accelerates Our Treatment

Process

Initiating Treatment ~5 Patients Per

Month

Eliminate HCV 2021*

HCV ELIMINATION

Thank You

Jessica Leston and David Stephens

NWPAIHB

Jessica Rienstra HCV Project

Coordinator

Kim Schiller HCV Project Assistant

Lummi HCV Cascade of Care

366 269

150 97 77

0

100

200

300

400

500

600

700

HCV Antibody + Estimated

HCV Antibody + Detected

HCV RNA Done

HCV RNA Positive

Evaluated Treated

56 %

65% 73%

Nu

mb

er o

f P

atie

nts

74%

79%

HCV ELIMINATION

All Patients Care About Treatment

Untreated bipolar, homeless/living on sail

boat,frequent drug use. YWCA, Shelter, ER.

Arrested Patient: “Not Without My Harvoni”